Cytogenetic tests

From Libre Pathology
Revision as of 20:32, 12 May 2011 by Michael (talk | contribs) (→ISH: more)
Jump to navigation Jump to search

Thsi article is a list of common cytogenetic tests. An introduction to cytogenetics is in the cytogenetics article.

Karyotyping

Findings:

ISH

Cytogenetic tests at one hospital:[3]

Test Parameters Notes
BCR/ABL1 CML or ALL Tx (imatinib)
MLL[4] ALL or AML rearrangment --> marker of poor prognosis[5]
MYC Burkitt's lymphoma + others prognostic
ALK DLBCL - BCL6, BCL2 or MYC ?
MALT1 MALT lymphoma trisomy 3, trisomy 18
CCND1 mantle cell lymphoma ?
BCL2 follicular lymphoma t(14;18)(q32;q21)[6]
ERBB2 (HER2) breast cancer prognostic, Tx (trastuzumab)
EWSR1 small round blue cell tumour (suspected Ewing sarcoma)

See also

References

  1. ↑ Nimer, SD. (Jun 2006). "Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.". J Clin Oncol 24 (16): 2576-82. doi:10.1200/JCO.2005.03.6715. PMID 16735711.
  2. ↑ Mallo, M.; Luño, E.; Sanzo, C.; Cervera, J.; Haase, D.; Schanz, J.; García-Manero, G.; Del Cañizo, C. et al. (Jan 2011). "Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.". Leuk Res. doi:10.1016/j.leukres.2011.01.003. PMID 21269692.
  3. ↑ Kamel-Reid, Suzanne. University Health Network / Department of Pathology. Cancer Cytogenetics & Molecular Diagnostics Laboratories. Test Requisition. August 2010.
  4. ↑ Online 'Mendelian Inheritance in Man' (OMIM) 159555
  5. ↑ Liedtke, M.; Cleary, ML. (Jun 2009). "Therapeutic targeting of MLL.". Blood 113 (24): 6061-8. doi:10.1182/blood-2008-12-197061. PMID 19289854.
  6. ↑ Yanai, S.; Nakamura, S.; Takeshita, M.; Fujita, K.; Hirahashi, M.; Kawasaki, K.; Kurahara, K.; Sakai, Y. et al. (Dec 2010). "Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.". Cancer. doi:10.1002/cncr.25811. PMID 21192062.